Richard Vincent R, Mitsa Georgia, Eshghi Azad, Chaplygina Daria, Mohammed Yassene, Goodlett David R, Zahedi Rene P, Thevis Mario, Borchers Christoph H
Segal Cancer Proteomics Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Quebec H3T 1E2, Canada.
Division of Experimental Medicine, McGill University, Montréal, Quebec H4A 3J1, Canada.
J Proteome Res. 2024 May 3;23(5):1779-1787. doi: 10.1021/acs.jproteome.4c00020. Epub 2024 Apr 24.
To prevent doping practices in sports, the World Anti-Doping Agency implemented the Athlete Biological Passport (ABP) program, monitoring biological variables over time to indirectly reveal the effects of doping rather than detect the doping substance or the method itself. In the context of this program, a highly multiplexed mass spectrometry-based proteomics assay for 319 peptides corresponding to 250 proteins was developed, including proteins associated with blood-doping practices. "Baseline" expression profiles of these potential biomarkers in capillary blood (dried blood spots (DBS)) were established using multiple reaction monitoring (MRM). Combining DBS microsampling with highly multiplexed MRM assays is the best-suited technology to enhance the effectiveness of the ABP program, as it represents a cost-effective and robust alternative analytical method with high specificity and selectivity of targets in the attomole range. DBS data were collected from 10 healthy athlete volunteers over a period of 140 days (28 time points per participant). These comprehensive findings provide a personalized targeted blood proteome "fingerprint" showcasing that the targeted proteome is unique to an individual and likely comparable to a DNA fingerprint. The results can serve as a baseline for future studies investigating doping-related perturbations.
为防止体育赛事中的兴奋剂使用行为,世界反兴奋剂机构实施了运动员生物护照(ABP)计划,通过长期监测生物变量来间接揭示兴奋剂的影响,而非检测兴奋剂物质或方法本身。在此计划背景下,开发了一种基于高分辨质谱的蛋白质组学检测方法,可检测对应250种蛋白质的319种肽段,其中包括与血液兴奋剂使用相关的蛋白质。利用多反应监测(MRM)技术建立了这些潜在生物标志物在毛细血管血(干血斑(DBS))中的“基线”表达谱。将DBS微量采样与高分辨MRM检测相结合,是提高ABP计划有效性的最适用技术,因为它是一种经济高效且稳健的替代分析方法,对阿托摩尔范围内的目标具有高特异性和选择性。在140天内(每位参与者28个时间点)从10名健康运动员志愿者身上收集了DBS数据。这些全面的研究结果提供了个性化的靶向血液蛋白质组“指纹”,表明靶向蛋白质组对个体而言是独一无二的,可能与DNA指纹相当。这些结果可为未来研究兴奋剂相关干扰提供基线。